======= FUCA2 =======
== Gene Information ==
* **Official Symbol**: FUCA2
* **Official Name**: alpha-L-fucosidase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2519|2519]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BTY2|Q9BTY2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=FUCA2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FUCA2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/136820|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a plasma alpha-L-fucosidase, which represents 10-20% of the total cellular fucosidase activity. The protein is a member of the glycosyl hydrolase 29 family, and catalyzes the hydrolysis of the alpha-1,6-linked fucose joined to the reducing-end N-acetylglucosamine of the carbohydrate moieties of glycoproteins. This enzyme is essential for Helicobacter pylori adhesion to human gastric cancer cells. [provided by RefSeq, Aug 2010].
* **UniProt Summary**: Alpha-L-fucosidase is responsible for hydrolyzing the alpha-1,6-linked fucose joined to the reducing-end N- acetylglucosamine of the carbohydrate moieties of glycoproteins.
|Alpha L fucos|
|alpha-L-fucosidase activity|
|regulation of entry of bacterium into host cell|
|glycoside catabolic process|
|fucose metabolic process|
|glycoside metabolic process|
|glycosyl compound catabolic process|
|azurophil granule lumen|
|glycosyl compound metabolic process|
|hexose metabolic process|
|carbohydrate derivative catabolic process|
|monosaccharide metabolic process|
|regulation of symbiosis, encompassing mutualism through parasitism|
|lysosome|
|endoplasmic reticulum lumen|
|post-translational protein modification|
|carbohydrate metabolic process|
|neutrophil degranulation|
|neutrophil activation involved in immune response|
|neutrophil mediated immunity|
|neutrophil activation|
|granulocyte activation|
|leukocyte degranulation|
|myeloid leukocyte mediated immunity|
|myeloid cell activation involved in immune response|
|myeloid leukocyte activation|
|leukocyte activation involved in immune response|
|cell activation involved in immune response|
|response to bacterium|
|regulated exocytosis|
|leukocyte mediated immunity|
|regulation of multi-organism process|
|exocytosis|
|leukocyte activation|
|secretion by cell|
|carbohydrate derivative metabolic process|
|export from cell|
|cell activation|
|immune effector process|
|secretion|
|response to other organism|
|response to external biotic stimulus|
|response to biotic stimulus|
|extracellular space|
|small molecule metabolic process|
|organic substance catabolic process|
|immune response|
|extracellular region|
|vesicle-mediated transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-1.8|
^Gene^Correlation^
|[[:human genes:h:hgc6.3|HGC6.3]]|0.525|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 9120
* **Expression level (log2 read counts)**: 2.53
{{:chemogenomics:nalm6 dist.png?nolink |}}